Medtronic plc

Medtronic acquired Digital Surgery, a private company developing digital surgical tools, to support its Hugo robotic surgery system. Financial terms were not disclosed.

ViewRay announced plans to collaborate with Medtronic and Elekta on clinical studies of its MRIdian MR-guided radiation therapy system. Elekta committed to investing up to $36 million for a 9.9% stake, and Medtronic will take an undisclosed stake.

Medtronic inaugurated a new production plant in El Coyol de Alajuela, Costa Rica, on September 11, 2019. The company expects to increase annual production from 6.5 million to 8.1 million units by 2021 and plans to hire about 500 people.

Medtronic inaugurated a new manufacturing facility in Coyol, Alajuela, Costa Rica, to produce components for spine surgery devices. The facility reinforces Medtronic's position as the largest employer of precision operators in the country.

Busamed Gateway Private Hospital partnered with Medtronic under the Surgical Synergy Framework to supply O-Arm 2 and StealthStation S8 surgical systems for neuro and spinal surgeries.

IntriCon secured a four-year Supply Agreement with Medtronic, its largest customer, for miniature and micro-miniature body-worn devices.

Medtronic closed its acquisition of Titan Spine, a maker of titanium interbody fusion devices. The deal was announced May 9, 2019, for an undisclosed amount.

Medtronic publicly disclosed a four-year collaboration with endoscope manufacturer Karl Storz to integrate 3D vision systems into its upcoming robot-assisted surgery platform. The partnership aims to support regulatory filings.

Medtronic has won a potential 10-year, $150 million contract from the Defense Logistics Agency to supply U.S. military branches and federal civilian agencies with radiology and imaging systems, components, and related services.

Medtronic closed its $1.7 billion acquisition of Mazor Robotics, and announced FDA 510(k) clearance for the jointly developed Mazor X Stealth device.

Medtronic Plc is acquiring Israeli nutrition data startup Nutrino Health Ltd. Financial terms were not disclosed, but estimated at around $100 million.

Mazor Robotics shareholders approved the definitive merger agreement with Medtronic plc, with Medtronic acquiring Mazor for approximately $1.64 billion.

Medtronic plc entered into a definitive merger agreement to acquire all outstanding shares of Mazor Robotics for approximately $1.64 billion, or $1.34 billion net of Medtronic's existing stake and cash acquired.

Medtronic won a $471.6 million contract from the US Department of Defense to supply cardiovascular products to the Army, Navy, Air Force, Marine Corps and federal civilian agencies, with a performance completion date of July 1, 2023.

Medtronic will buy Israeli medical device developer Visionsense for $75 million, including $40-50 million cash and $25 million in milestone payments. Visionsense develops minimally invasive surgical devices for brain surgery.

Medtronic inaugurated its fourth manufacturing plant in the Dominican Republic, located in the San Isidro free zone park, with an investment of approximately $46 million, creating over 450 jobs for neurosurgery device production.

Medtronic was awarded a contract by L'Hôpital Nord Franche-Comté for the supply of Synchromed pumps and consumables, valued at EUR 658,300. The award was made on February 21, 2018.

Medtronic and Royal Philips entered a business relationship to develop and commercialize the LungGPS Patient Management Platform for managing lung nodule patients from identification through treatment.

Medtronic has completed the $28 million sale of QT Vascular's Chocolate PTA balloon catheter, following a prior distribution agreement and option triggers.

Medtronic purchased Crospon Limited, an Irish-based medical device company, in an estimated $44.8 million deal.

Medtronic Ltd was awarded a contract by Golden Jubilee Hospital (National Waiting Times Centre Board) for electrophysiology cath lab consumables, valued at GBP 396,000. The award was granted on December 20, 2017.

Medtronic Care Management Services commenced launch of new telehealth solutions in support of its national contract with the U.S. Department of Veterans Affairs for Home Telehealth Devices and Services.

Mazor Robotics and Medtronic amended their strategic partnership, with Medtronic assuming exclusive worldwide distribution of the Mazor X system and making a $40 million third tranche investment in Mazor. Approximately 30 Mazor sales members are expected to join Medtronic.

Medtronic has announced an expansion for its plant in Tijuana with an investment of nearly US$11 million to increase product offerings. The plant manufactures catheters and heart valves.

QT Vascular entered into an asset purchase option agreement with Medtronic, giving Medtronic the option to acquire QT Vascular's non-drug coated Chocolate PTA balloon for $28 million, exercisable upon achievement of certain milestones.

Medtronic is expanding its Greenwood County, South Carolina facility with a $6.5 million investment in a new production line. The line will be capable of producing up to 9,000 finished good units per day to meet increased customer demand.

Stentex, a joint venture between Renova Group and Medtronic, is investing about 9 billion rubles in a production complex for coronary stents and catheters in Russia. At peak capacity in 2022, it plans to produce 250,000 stents per year and create about 700 jobs.

Cardinal Health has agreed to acquire Medtronic's Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses for $6.1 billion in cash. The transaction is expected to close in Q1 of Cardinal Health's fiscal year 2018.

ConvaTec is expanding its Unomedical infusion set business to increase production capacity for Medtronic's insulin pump consumables, as part of a long-standing partnership.

Qt Vascular Ltd signed a definitive agreement with Medtronic Inc for worldwide distribution of its Chocolate PTA Catheter for a period of 5 years.